| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.0043 | 1 |